Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Surrogate functional biomarker for solid tumor cancer
Eutropics Pharmaceuticals, Inc.
April 12, 2018 - N°20180100859

The present invention relates to diagnostic methods that are relevant to various solid tumor cancers that are not amenable to traditional bih3 profiling diagnostic methods. In some embodiments, the methods described herein are useful in the evaluation of a patient, for example, for evaluating diagnosis, prognosis, and response to treatment. In various aspects, the present disclosure includes evaluating a solid ...
Protein biomarker panels for detecting colorectal cancer and advanced adenoma
Applied Proteomics, Inc.
April 12, 2018 - N°20180100858

Disclosed herein are panels related to the diagnosis or recognition of advanced adenoma and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a ...
Method for identifying or detecting genomic rearrangements in a biological sample
Genomic Vision
April 12, 2018 - N°20180100202

A method for detection, visualization and/or comparison of polynucleotide sequences of interest using specially designed sets of long and short probes that enhance resolution and simplify visualization and detection. Probe compositions useful for practicing this method and procedures for identifying useful probes and probe combinations. These methods are useful for the detection of genomic rearrangements, especially those associated with ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dna methylation markers for metastatic prostate cancer
The Johns Hopkins University
April 12, 2018 - N°20180100196

The present invention relates to the field of cancer. More specifically, the present invention provides methods and compositions useful for assessing prostate cancer. In a specific embodiment, present inventors have developed and applied a new technology and associated computation methods enabling simultaneous genome-scale analysis of genetic (copy number) and epigenetic (total methylation (tm) and allele-specific methylation (asm) alternation, this method, ...
Method and kit for use in inhiiting tumor progression, predicting or determining tumor progression state ...
Truebio Llc
April 12, 2018 - N°20180100153

The present invention provides a method of inhibiting tumor progression in a subject suffering from vgf expressing cancers. The present invention also provides a method and a kit of predicting or determining tumor progression state in a subject suffering from vgf expressing cancers.
Organic compositions to treat epas1 - related diseases
Arrowhead Pharmaceuticals, Inc.
April 12, 2018 - N°20180100151

The present disclosure relates to methods of treating epas1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Prostate-specific membrane antigen binding proteins and related compositions and methods
Aptevo Research And Development Llc
April 12, 2018 - N°20180100021

The present invention relates to mono-specific and multi-specific polypeptide therapeutics that specifically target cells expressing prostate-specific membrane antigen (psma) and are useful for the treatment of prostate cancer (e. G., castrate-resistant prostate cancer), tumor-related angiogenesis or benign prostatic hyperplasia (bph). In one embodiment, the multi-specific poly-peptide therapeutics bind both psma-expressing cells and the t-cell receptor complex on t cells to ...
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic ...
Mayo Foundation For Medical Education And Research
April 12, 2018 - N°20180100015

The invention features methods of diagnosis by assessing b7-h1 expression in a tissue from a subject that has, or is suspected of having, cancer, methods of treatment with agents that interfere with b7-h1-receptor interaction, methods of selecting candidate subjects likely to benefit from cancer immunotherapy, and methods of inhibiting expression of b7-h1.
Novel compounds as rearranged during transfection (ret) inhibitors
Glaxosmithkline Intellectual Property Development Limited
April 12, 2018 - N°20180099976

This invention relates to novel compounds which are inhibitors of the rearranged during transfection (ret) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of gastrointestinal sensitivity, motility and/or secretion and/or abdominal disorders or diseases and/or treatment related to diseases related to ...
Process for the preparation of androgen receptor antagonists and intermediates thereof
Orion Corporation
April 12, 2018 - N°20180099938

The present invention relates to an improved process for the preparation of carboxamide structured androgen receptor (ar) antagonists such as n—((s)-1-(3-(3-chloro-4-cyanophenyl)-1h-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1h-pyrazole-3-carboxamide (1a) and key intermediates thereof such as 2-chloro-4-(1h-pyrazol-3-yl)benzonitrile (v). Ar antagonists are useful in the treatment of ...
Anti-fugetactic agents for the treatment of cancers
The General Hospital Corporation
April 12, 2018 - N°20180099037

This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
Antifugetactic agents for the treatment of cancers
The General Hospital Corporation
April 12, 2018 - N°20180099036

This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides antifugetactic agents and methods for the use thereof in enhancing an immune response.
Antifugetactic agents for the treatment of cancers
The General Hospital Corporation
April 12, 2018 - N°20180099035

This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Topical drug for treating breast cancer and preparation method thereof
April 12, 2018 - N°20180099021

Disclosed is a topical drug for treating breast cancer and preparation method thereof. The topical drug comprises the following ingredients in parts by weight: 5-10 parts of astragalus, 3-5 parts of oldenlandia diffusa, 3-5 parts of dandelion, 5-10 parts of lycoris radiate, 5-8 parts of carapax trionycis, 3-5 parts of pinellia pedatisecta, 2-3 parts of acorus calamus, 3-5 parts of ...
Detargeted adenovirus variants and related methods
April 12, 2018 - N°20180099015

The present disclosure describes the generation and the use of ad variants (ad) possessing any combination of mutations in genes that code for the hexon, penton, fiber, and non-structural proteins, where simultaneous modification of hexon and penton are made to avoid the trapping of ad in the liver and to reduce toxicity after intravascular virus administration. Such liver de-targeted ad ...
Engineered oncolytic viruses containing hyper-binding sites to sequester and suppress activity of oncogenic transcription factors ...
Miami University
April 12, 2018 - N°20180099014

In one or more embodiments, the present invention provides novel artificial, non-naturally-occurring double stranded dna segments (and related methods) capable of acting as decoy binding sites for oncogenic transcription factors and a general method for suppressing aberrant activity of oncogenic transcription factors that promote cancer progression. In various embodiments, the present invention involves the sequestration of targeted oncogenic transcription factors ...
Tumor-selective combination therapy
The Board Of Trustees Of The University Of Illinois
April 12, 2018 - N°20180099002

The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of nqo1.
Lasofoxifene treatment of breast cancer
Duke University
April 12, 2018 - N°20180098963

The disclosure provides methods for treating estrogen receptor positive (er+) cancer in women with an effective amount of lasofoxifene, a pharmaceutically acceptable salt thereof, or a prodrug thereof. The disclosure also includes the detection of the estrogen receptor 1 (esr1) gene mutations that lead to endocrine resistance and treatment of endocrine resistant er+ cancers.
Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment ...
Flavocure Biotech Llc
April 12, 2018 - N°20180098961

An embodiment of the invention provides a cannabis-based flavonoid pharmaceutical composition including any one or more selected, from among the group of apigenin, cannflavin. A. Cannflavin b, cannflavin c, chrysoeriol, cosmosiin, flavocannabiside, kaempferol, luteolin, myricetin, orientin, isoorientin (homoorientin), quercetin (+)-taxifolin, vitexin, and isovitexin, or their synthases, for the prevention and treatment of certain cancers that can be treated by therapeutically ...
Method for treating bladder cancer
April 12, 2018 - N°20180098958

A method for treating bladder cancer including the steps of administering an isothiocyanate functional surfactant to an area affected by bladder cancer, wherein the isothiocyanate functional surfactant comprises at least one isothiocyanate functional group associated with an aliphatic and/or aromatic carbon atom of the isothiocyanate functional surfactant.
Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud,dba Champalimaud Fnd.
April 05, 2018 - N°20180096742

Clinical information, molecular information and/or computer-generated morphometric information is used in a predictive model for predicting the occurrence of a medical condition. In an embodiment, a model predicts risk of prostate cancer progression in a patient, where the model is based on features including one or more (e. G., all) of preoperative psa, dominant gleason grade, gleason score, at ...
Loading